Lista de obras - Laurent Degos - Dominio Público Uruguay

A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group

artículo científico publicado en 1999

All trans retinoic acid in acute promyelocytic leukemia

artículo científico publicado en 2001

Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia

artículo científico publicado en 1997

Clinical investigation of lithium therapy in acute leukemia.

artículo científico publicado en 1980

Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia

artículo científico publicado en 2003

Erythema multiforme is associated to HLA-Aw33 and DRw53

artículo científico publicado en 1988

In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia

artículo científico publicado en 2002

Jean Bernard. Medicine, science, humanity

artículo científico publicado en 2006

Long-term follow-up of European APL 2000 trial, evaluating the role of cytarabine combined with ATRA and Daunorubicin in the treatment of nonelderly APL patients

artículo científico publicado en 2013

Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trials

artículo científico publicado en 2014

Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendations

artículo científico publicado en 2002

Meeting report: the 11th International Conference on Differentiation Therapy and Innovative Therapeutics in Oncology.

artículo científico publicado en 2007

Molecular target-based treatment of human cancer: summary of the 10th international conference on differentiation therapy.

artículo científico publicado en 2005

PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors

artículo científico publicado en 1994

Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome

artículo científico publicado en 2010

Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient